Paper17540344
Relevance of extracellular and intracellular interactions of camptothecins as determinants of antitumor activity.
Beretta GL and 1 other. Biochem Pharmacol, 2007. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Relevance of extracellular and intracellular interactions of camptothecins as determinants of antitumor activity. Papers, record 17540344. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17540344
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Relevance of extracellular and intracellular interactions of camptothecins as determinants of antitumor activity.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents, Phytogenic | Major topic |
| Camptothecin | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Blood Proteins | |
| DNA Topoisomerases, Type I | |
| Humans |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39458656 | Endosomal pH, Redox Dual-Sensitive Prodrug Micelles Based on Hyaluronic Acid for Intracellular Camptothecin Delivery and Active Tumor Targeting in Cancer Therapy. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39458656 | PubMed |
| 36612067 | Nanoplatform for the Delivery of Topotecan in the Cancer Milieu: An Appraisal of its Therapeutic Efficacy. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36612067 | PubMed |
| 31556849 | The Emerging Role of the SLCO1B3 Protein in Cancer Resistance. | Protein Pept Lett | 2020 | https://conductscience.org/library/papers/31556849 | PubMed |
| 31546717 | Rapid Microfluidic Preparation of Niosomes for Targeted Drug Delivery. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31546717 | PubMed |
| 24980734 | Tumor regression achieved by encapsulating a moderately soluble drug into a polymeric thermogel. | Sci Rep | 2014 | https://conductscience.org/library/papers/24980734 | PubMed |
| 22740943 | Rapid deconjugation of SN-38 glucuronide and adsorption of released free SN-38 by intestinal microorganisms in rat. | Oncol Lett | 2012 | https://conductscience.org/library/papers/22740943 | PubMed |
| 19303306 | 12-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridines as novel topoisomerase I-targeting antitumor agents. | Bioorg Med Chem | 2009 | https://conductscience.org/library/papers/19303306 | PubMed |
| 18982460 | Glutamate regulates the activity of topoisomerase I in mouse cerebellum. | Mol Neurobiol | 2008 | https://conductscience.org/library/papers/18982460 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17540344
GET https://conductscience.org/api/papers/v1/17540344/authors